7/2/2020  9:59:57 PM Chg. +2.48 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
289.95USD +0.86% 34,174
Turnover: 9.86 mill.
-Bid Size: - -Ask Size: - 15.47 bill.USD 0.02% 30.73

Business description

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA.

Management board & Supervisory board

Albert G. White, III
Management board
Brian Andrews, Agostino Ricupati, Daniel G. McBride, Holly Sheffield, Randy Golden, Robert D. Auerbach
Supervisory board
A. Thomas Bender, Albert G. White, III, Allan E. Rubenstein, Colleen E. Jay, Gary S. Petersmeyer, Jody S. Lindell, Michael H. Kalkstein, Robert S. Weiss, William A. Kozy

Company data

Name: Cooper Companies Inc.
Address: 6140 Stoneridge Mall Road, Suite 590,Pleasanton, CA 94588, USA
Phone: +1-925-460-3600
Fax: -
E-mail: -
Internet: www.coopercos.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 10/31
Free Float: 46.67%
IPO date: -

Investor relations

Name: Kim Duncan
IR phone: +1-925-460-3663
IR Fax: -
IR e-mail: ir@cooperco.com

Main Shareholders

T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock, Inc.
Generation Investment Management LLP
Massachusetts Financial Services Company
Janus Henderson Group PLC
State Street Corporation